Table 3.
Swedish universities Scales of Personality (SSP) raw scores (mean [standard deviation]) and 95% confidence interval (CI) of the difference between baseline and follow-up in patients with psychotic illness and non-psychotic controls
| Somatic Trait Anxiety | Psychic Trait Anxiety | Stress Susceptibility | |||||||||
| N | Baseline | Follow-up | CI | Baseline | Follow-up | CI | Baseline | Follow-up | CI | ||
| ALL | Patient | 36 | 39.4 (7.7) | 44.4 (7.8) | −0.25 – 0.15 | 2.08 (0.48) | 2.13 (0.53) | −0.09 – 0.27 | 2.45 (0.62) | 2.36 (0.61) | −0.19 – 0.16 |
| Control | 76 | 41.1 (7.8) | 47.5 (7.8) | −0.06 – 0.12 | 1.58 (0.46) | 1.55 (0.45) | 0.11–0.26 | 1.66 (0.50) | 1.48 (0.39) | −0.05 – 0.14 | |
| ALL | Men | 75 | 40.7 (7.9) | 46.5 (8.0) | −0.14 – 0.08 | 1.68 (0.48) | 1.71 (0.56) | 0.04–0.22 | 1.92 (0.68) | 1.79 (0.66) | −0.06 – 0.14 |
| Women | 37 | 40.1 (7.7) | 46.4 (7.9) | −0.08 – 0.21 | 1.74 (0.52) | 1.78 (0.53) | 0.07–0.34 | 1.90 (0.60) | 1.70 (0.55) | −0.17 – 0.16 | |
| PATIENT | Men | 28 | 39.9 (7.5) | 44.9 (7.6) | −0.39 – 0.09 | 2.05 (0.39) | 2.19 (0.51) | −0.17 – 0.24 | 2.47 (0.60) | 2.43 (0.52) | −0.24 – 0.17 |
| Women | 8 | 37.5 (8.2) | 42.6 (8.2) | 0.02–0.55 | 2.21 (0.71) | 1.93 (0.57) | −0.17 – 0.74 | 2.38 (0.71) | 2.09 (0.84) | −0.40 – 0.51 | |
| CONTROL | Men | 47 | 41.2 (8.1) | 47.5 (8.0) | −0.06 – 0.14 | 1.47 (0.39) | 1.43 (0.36) | 0.10–0.28 | 1.60 (0.49) | 1.41 (0.37) | −0.02 – 0.20 |
| Women | 29 | 40.8 (7.4) | 47.5 (7.5) | −0.16 – 0.18 | 1.75 (0.71) | 1.74 (0.52) | 0.04–0.33 | 1.77 (0.51) | 1.59 (0.40) | −0.21 – 0.17 | |
| Lack of Assertiveness | Impulsiveness | Adventure Seeking | |||||||||
| Baseline | Follow-up | CI | Baseline | Follow-up | CI | Baseline | Follow-up | CI | |||
| ALL | Patient | 2.46 (0.55) | 2.47 (0.53) | −0.13 – 0.28 | 2.33 (0.52) | 2.25 (0.51) | −0.07 – 0.23 | 2.50 (0.58) | 2.38 (0.61) | 10.04–0.29 | |
| Control | 1.87 (0.47) | 1.82 (0.44) | −0.04 – 0.11 | 2.30 (0.46) | 2.19 (0.47) | 0.02–0.20 | 2.53 (0.52) | 2.39 (0.51) | 0.07–0.22 | ||
| ALL | Men | 2.06 (0.61) | 2.02 (0.58) | −0.06 – 0.16 | 2.23 (0.47) | 2.15 (0.47) | −0.01 – 0.17 | 2.57 (0.58) | 2.42 (0.56) | 0.06–0.25 | |
| Women | 2.04 (0.46) | 2.05 (0.53) | −0.07 – 0.15 | 2.48 (0.45) | 2.34 (0.49) | 0.01–0.28 | 2.42 (0.43) | 2.33 (0.50) | −0.01 – 0.21 | ||
| PATIENT | Men | 2.48 (0.60) | 2.52 (0.46) | −0.18 – 0.33 | 2.28 (0.51) | 2.21 (0.52) | −0.12 – 0.24 | 2.52 (0.62) | 2.34 (0.65) | −0.02 – 0.38 | |
| Women | 2.36 (0.38) | 2.30 (0.76) | −0.21 – 0.35 | 2.52 (0.51) | 2.38 (0.48) | −0.22 – 0.49 | 2.46 (0.39) | 2.54 (0.46) | −0.33 – 0.19 | ||
| CONTROL | Men | 1.81 (0.47) | 1.72 (0.41) | −0.06 – 0.13 | 2.19 (0.44) | 2.11 (0.44) | −0.02 – 0.20 | 2.61 (0.55) | 2.47 (0.51) | 0.04–0.24 | |
| Women | 1.96 (0.45) | 1.98 (0.44) | −0.09 – 0.16 | 2.47 (0.44) | 2.33 (0.50) | −0.00 – 0.30 | 2.41 (0.44) | 2.27 (0.50) | 0.02–0.27 | ||
| Detachment | Social Desirability | Embitterment | |||||||||
| Baseline | Follow-up | CI | Baseline | Follow-up | CI | Baseline | Follow-up | CI | |||
| ALL | Patient | 2.77 (0.53) | 2.83 (0.45) | −0.14 – 0.17 | 2.77 (0.53) | 2.83 (0.45) | −0.24 – 0.13 | 2.23 (0.50) | 2.22 (0.55) | −0.15 – 0.17 | |
| Control | 2.83 (0.37) | 2.92 (0.35) | −0.02 – 0.12 | 2.83 (0.37) | 2.92 (0.35) | −0.15 - -0.03 | 1.60 (0.41) | 1.47 (0.40) | 0.05–0.20 | ||
| ALL | Men | 2.80 (0.43) | 2.88 (0.39) | −0.05 – 0.12 | 2.80 (0.43) | 2.88 (0.39) | −0.16 – 0.00 | 1.82 (0.52) | 1.72 (0.59) | 0.01–0.20 | |
| Women | 2.82 (0.42) | 2.90 (0.38) | −0.09 – 0.18 | 2.82 (0.42) | 2.90 (0.38) | −0.21 – 0.06 | 1.75 (0.56) | 1.69 (0.59) | −0.06 – 0.18 | ||
| PATIENT | Men | 2.82 (0.56) | 2.80 (0.46) | −0.14 – 0.20 | 2.82 (0.56) | 2.80 (0.46) | −0.18 – 0.21 | 2.23 (0.44) | 2.23 (0.57) | −0.20 – 0.20 | |
| Women | 2.61 (0.42) | 2.91 (0.44) | −0.51 – 0.48 | 2.61 (0.42) | 2.91 (0.44) | −0.87 – 0.26 | 2.23 (0.69) | 2.17 (0.51) | −0.22 – 0.34 | ||
| CONTROL | Men | 2.79 (0.34) | 2.93 (0.34) | −0.05 – 0.13 | 2.79 (0.34) | 2.93 (0.34) | −0.21 - − 0.07 | 1.58 (0.39) | 1.42 (0.34) | 0.08–0.25 | |
| Women | 2.88 (0.41) | 2.90 (0.36) | -0.07 – 0.20 | 2.88 (0.41) | 2.90 (0.36) | −0.12 – 0.09 | 1.62 (0.45) | 1.56 (0.47) | −0.08 – 0.20 | ||
| Trait Irritability | Mistrust | ||||||||||
| Baseline | Follow-up | CI | Baseline | Follow-up | CI | ||||||
| ALL | Patient | 2.35 (0.57) | 2.13 (0.57) | 0.03–0.40 | 2.26 (0.58) | 2.26 (0.52) | −0.13 – 0.15 | ||||
| Control | 2.21 (0.48) | 2.03 (0.49) | 0.09–0.26 | 1.75 (0.50) | 1.60 (0.47) | 0.06–0.24 | |||||
| ALL | Men | 2.26 (0.49) | 2.04 (0.53) | 0.12–0.31 | 1.97 (0.56) | 1.86 (0.57) | 0.02–0.21 | ||||
| Women | 2.24 (0.55) | 2.11 (0.50) | −0.03 – 0.29 | 1.81 (0.59) | 1.72 (0.58) | −0.03 – 0.21 | |||||
| PATIENT | Men | 2.36 (0.56) | 2.16 (0.53) | 0.01–0.38 | 2.28 (0.58) | 2.25 (0.53) | −0.14 – 0.21 | ||||
| Women | 2.32 (0.66) | 2.04 (0.74) | −0.37 – 0.94 | 2.20 (0.62) | 2.29 (0.55) | −0.24 – 0.07 | |||||
| CONTROL | Men | 2.20 (0.45) | 1.97 (0.51) | 0.11–0.34 | 1.79 (0.47) | 1.62 (0.47) | 0.05–0.28 | ||||
| Women | 2.22 (0.48) | 2.13 (0.43) | −0.05 – 0.22 | 1.70 (0.54) | 1.56 (0.49) | −0.01 -0.29 | |||||
| Verbal Trait Aggression | Physical Trait Aggression | ||||||||||
| Baseline | Follow-up | CI | Baseline | Follow-up | CI | ||||||
| ALL | Patient | 2.01 (0.64) | 2.00 (0.55) | −0.19 – 0.20 | 1.71 (0.57) | 1.84 (0.60) | −0.31 – 0.07 | ||||
| Control | 2.15 (0.47) | 1.96 (0.46) | 0.10–0.28 | 1.93 (0.57) | 1.67 (0.54) | 0.17–0.35 | |||||
| ALL | Men | 2.12 (0.53) | 2.02 (0.58) | −0.01 – 0.21 | 1.92 (0.60) | 1.81 (0.59) | 0.00–0.23 | ||||
| Women | 2.07 (0.55) | 1.88 (0.43) | 0.04–0.33 | 1.73 (0.53) | 1.55 (0.46) | 0.01–0.33 | |||||
| PATIENT | Men | 2.03 (0.62) | 2.07 (0.58) | −0.26 – 0.18 | 1.76 (0.59) | 1.86 (0.66) | −0.33 – 0.13 | ||||
| Women | 1.95 (0.74) | 1.79 (0.38) | −0.37 – 0.69 | 1.54 (0.47) | 1.74 (0.39) | −0.57 – 0.16 | |||||
| CONTROL | Men | 2.18 (0.46) | 2.00 (0.48) | 0.07–0.31 | 2.02 (0.58) | 1.78 (0.55) | 0.14–0.35 | ||||
| Women | 2.10 (0.50) | 1.91 (0.44) | 0.04–0.34 | 1.78 (0.54) | 1.50 (0.47) | 0.11–0.44 | |||||
Data is shown by diagnosis (patient vs control) in all subjects, gender in all subjects, gender among patients and gender among controls